Literature DB >> 17316880

Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons.

Paola Trombini, Alberto Piperno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17316880     DOI： 10.1016/j.jhep.2007.01.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  18 in total

1.  Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Malgorzata Lawniczak; Joanna Miezynska-Kurtycz; Jan Lubinski
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  Dietary iron to total energy intake ratio and type 2 diabetes incidence in a longitudinal 12-year analysis of the Korean Genome and Epidemiology Cohort Study.

Authors:  Dong-Hyuk Jung; Kyeng Won Hong; Byoungjin Park; Yong-Jae Lee
Journal:  Eur J Nutr       Date:  2021-06-03       Impact factor: 5.614

3.  Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome.

Authors:  Paola Trombini; Valentina Paolini; Sara Pelucchi; Raffaella Mariani; Elizabeta Nemeth; Tomas Ganz; Alberto Piperno
Journal:  Liver Int       Date:  2011-04-18       Impact factor: 5.828

Review 4.  Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Authors:  Ludovico Abenavoli; Natasa Milic; Valentina Peta; Francesco Alfieri; Antonino De Lorenzo; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

5.  Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome.

Authors:  Alessia Riva; Paola Trombini; Raffaella Mariani; Alessandra Salvioni; Sabina Coletti; Silvia Bonfadini; Valentina Paolini; Matteo Pozzi; Rita Facchetti; Giorgio Bovo; Alberto Piperno
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

6.  Hyperferritinemia is a risk factor for steatosis in chronic liver disease.

Authors:  Anna Licata; Maria Elena Nebbia; Giuseppe Cabibbo; Giovanna Lo Iacono; Francesco Barbaria; Virna Brucato; Nicola Alessi; Salvatore Porrovecchio; Vito Di Marco; Antonio Craxì; Calogero Cammà
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

7.  High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats.

Authors:  Rosaria Meli; Giuseppina Mattace Raso; Carlo Irace; Raffaele Simeoli; Antonio Di Pascale; Orlando Paciello; Teresa Bruna Pagano; Antonio Calignano; Alfredo Colonna; Rita Santamaria
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

8.  Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Authors:  Rachel M Williamson; Jackie F Price; Stephen Glancy; Elisa Perry; Lisa D Nee; Peter C Hayes; Brian M Frier; Liesbeth A F Van Look; Geoffrey I Johnston; Rebecca M Reynolds; Mark W J Strachan
Journal:  Diabetes Care       Date:  2011-04-08       Impact factor: 19.112

Review 9.  Hyperferritinemia-A Clinical Overview.

Authors:  Miriam Sandnes; Rune J Ulvik; Marta Vorland; Håkon Reikvam
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

10.  Hepcidin expression in iron overload diseases is variably modulated by circulating factors.

Authors:  Giulia Ravasi; Sara Pelucchi; Paola Trombini; Raffaella Mariani; Naohisa Tomosugi; Giulia Litta Modignani; Matteo Pozzi; Elizabeth Nemeth; Tomas Ganz; Hisao Hayashi; Donatella Barisani; Alberto Piperno
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.